Phase I study of a therapeutic vaccine in ATL patients with autologous dendritic cells pulsed with Tax peptides
Phase 1
- Conditions
- Adult T cell leukemia/lymphoma
- Registration Number
- JPRN-UMIN000011423
- Lead Sponsor
- ational Hospital Organization Kyushu Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with severe complications: cardiovascular disorders, respiratory disorders, renal dysfunction, immunodeficiency, hematological disorders, autoimmune diseases, sever allergy and severe infectious disease. 2) Patients who should receive systemic administration of steroid or immunosuppressive agents. 3) Presence of active brain metastases 4) Pregnant, lactating, or possiblly pregnant women, or willing to be pregnant 5) Severe psychiatric disorder 6) History of HAM/TSP 7) Active multiple cancers 8) Inappropriate for study entry judged by an attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method